MIMEDX GROUP, INC.
MDXGdata completeness 88%16 fiscal years on fileMIMEDX GROUP, INC. earns about -34% on invested capital, but has diluted owners by 36% over 5 years — worth asking whether the growth reaches owners. The applicable estimate puts fair value near $2.94 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $242M1 | $267.8M2 | $321.5M3 | $348.9M3 | $418.6M3 |
| Net income | −$10.3M4 | −$30.2M5 | $58.2M6 | $42.4M6 | $48.6M6 |
| Operating cash flow | −$1.98M7 | −$17.9M8 | $26.8M9 | $66.2M9 | $74M9 |
| Capital expenditure | $3.22M10 | $1.51M10 | $1.99M10 | — | — |
| Free cash flow (derived) | −$5.2M7 | −$19.4M8 | $24.8M9 | — | — |
| Total debt | $98.1M11 | $98.6M12 | $99.1M13 | $37.8M14 | $36M14 |
| Cash & equivalents | $87.1M15 | $66M16 | $82M17 | $104.4M18 | $166.1M18 |
| Diluted shares | 110.4M | 112.9M | 146.0M | 149.0M | 149.7M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on $17.13 of net worth that earned you $3.24 last year, against $2.4 of debt.
It earned an average -34% on invested capital over 5 years. Compare that to what it costs to fund the business.
seeing a moat in the numbers →Share count is up 36% over 5 years — owners have been diluted. Worth asking what they got for it. Total debt has fallen 63% — deleveraging.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$42.4M
- growthAssumed0.0%
assumptions (1)
- grahamMultiplier2250.0%
Different models answer different questions — which to trust when →
- 10-K · period ending 2021-12-31 · accession 0001376339-24-000009 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2022-12-31 · accession 0001376339-25-000009 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2023-12-31 · accession 0001376339-26-000011 (RevenueFromContractWithCustomerExcludingAssessedTax)
- 10-K · period ending 2021-12-31 · accession 0001376339-24-000009 (NetIncomeLoss)
- 10-K · period ending 2022-12-31 · accession 0001376339-25-000009 (NetIncomeLoss)
- 10-K · period ending 2023-12-31 · accession 0001376339-26-000011 (NetIncomeLoss)
- 10-K · period ending 2021-12-31 · accession 0001376339-24-000009 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-12-31 · accession 0001376339-25-000009 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-12-31 · accession 0001376339-26-000011 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-12-31 · accession 0001376339-24-000009 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-12-31 · accession 0001376339-23-000003 (LongTermDebtNoncurrent)
- 10-K · period ending 2022-12-31 · accession 0001376339-24-000009 (LongTermDebtNoncurrent)
- 10-K · period ending 2023-12-31 · accession 0001376339-25-000009 (LongTermDebtNoncurrent)
- 10-K · period ending 2024-12-31 · accession 0001376339-26-000011 (LongTermDebtNoncurrent)
- 10-K · period ending 2021-12-31 · accession 0001376339-23-000003 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-12-31 · accession 0001376339-24-000009 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-12-31 · accession 0001376339-25-000009 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-12-31 · accession 0001376339-26-000011 (CashAndCashEquivalentsAtCarryingValue)